CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Idera Pharmaceuticals, Inc.  (IDRA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 
 

IDRA's Revenue Year on Year Growth by Quarter and Year

Idera Pharmaceuticals,'s Revenue results by quarter and year



Select the Comparisons : Select the Ratio:                        
IDRA Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - 15.28 0.19 -
III Quarter September - 0.32 0.02 0.03
II Quarter June 0.19 0.30 0.01 0.04
I Quarter March 0.38 0.29 0.03 -
FY   0.57 16.19 0.25 0.07

Financial Statements
Idera Pharmaceuticals,'s second quarter 2017 Revenue $ 0.19 millions IDRA's Income Statement
Idera Pharmaceuticals,'s second quarter 2016 Revenue $ 0.30 millions Quarterly IDRA's Income Statement
IDRA's Growth by Division See IDRA's Growth by Segment

IDRA Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - 7942.11 % - -
III Quarter September - 1500 % -33.33 % 200 %
II Quarter June -37.67 % 2900 % -75 % 33.33 %
I Quarter March 31.03 % 866.67 % - -
FY   - 6376 % 257.14 % -



IDRA Revenue Growth Comment
Idera Pharmaceuticals, Inc. reported fall in Revenue in the second quarter by -37.67% to $ 0.19 millions, from the same quarter in 2016.
The drop in the second quarter Idera Pharmaceuticals, Inc.'s Revenue compares unfavorably to the Company's average Revenue doubling of 1486.09%.

Looking into second quarter results within Biotechnology & Drugs industry 66 other companies have achieved higher Revenue growth. While Idera Pharmaceuticals, Inc.' s Revenue drop of -37.67% ranks overall at the positon no. 3115 in the second quarter.



Revenue Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #67
Healthcare Sector #372
Overall #3115
Revenue Y/Y Growth Statistics
High Average Low
9400 % 1486.09 % -86.84 %
(Dec 31 2015)   (Jun 30 2015)

You need to upgrade your Flash Player

Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
IDRA's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for IDRA's Competitors
Revenue Growth for Idera Pharmaceuticals,'s Suppliers
Revenue Growth for IDRA's Customers

You may also want to know
IDRA's Annual Growth Rates IDRA's Profitability Ratios IDRA's Asset Turnover Ratio IDRA's Dividend Growth
IDRA's Roe IDRA's Valuation Ratios IDRA's Financial Strength Ratios IDRA's Dividend Payout Ratio
IDRA's Roa IDRA's Inventory Turnover Ratio IDRA's Growth Rates IDRA's Dividend Comparisons



Companies with similar Revenue drop for the quarter ending Jun 30 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2017
Fate Therapeutics Inc -0.10 %$ -0.097 millions
Psychemedics Corp -0.17 %$ -0.165 millions
Halyard Health, Inc. -0.20 %$ -0.200 millions
Xtant Medical Holdings, Inc. -0.25 %$ -0.249 millions
Ocular Therapeutix, Inc. -0.68 %$ -0.680 millions
Emergent Biosolutions Inc. -0.70 %$ -0.705 millions
Tenet Healthcare Corp -0.90 %$ -0.900 millions
Genmark Diagnostics, Inc. -1.22 %$ -1.223 millions
Trovagene, Inc. -1.34 %$ -1.343 millions
Mymetics Corp -1.86 %$ -1.858 millions
Vaso Corp -1.98 %$ -1.982 millions
Recro Pharma, Inc. -2.00 %$ -1.997 millions
Inc Research Holdings, Inc. -2.13 %$ -2.130 millions
Quorum Health Corporation -2.16 %$ -2.165 millions
China Biologic Products Holdings, Inc. -2.34 %$ -2.344 millions
Msa Safety Incorporated -2.44 %$ -2.440 millions
Pacific Biosciences Of California, Inc. -3.25 %$ -3.249 millions
T2 Biosystems, Inc. -3.43 %$ -3.434 millions
Therapeuticsmd, Inc. -3.47 %$ -3.470 millions
Harvard Bioscience Inc -3.53 %$ -3.532 millions
Twinlab Consolidated Holdings, Inc. -3.61 %$ -3.614 millions
Acceleron Pharma Inc -4.32 %$ -4.319 millions
Conformis Inc -4.39 %$ -4.391 millions
Endologix Inc -4.74 %$ -4.744 millions
Steris Plc -4.76 %$ -4.764 millions
Becton Dickinson & Co -5.10 %$ -5.097 millions
Cancer Genetics, Inc -5.67 %$ -5.671 millions
Brookdale Senior Living Inc. -5.75 %$ -5.748 millions
Cord Blood America, Inc. -5.91 %$ -5.907 millions
Genesis Healthcare, Inc. -6.06 %$ -6.055 millions